Filing Details
- Accession Number:
- 0001179110-17-014822
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-04 15:56:08
- Reporting Period:
- 2017-12-01
- Accepted Time:
- 2017-12-04 15:56:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1509415 | P Christopher Leamon | 3000 Kent Ave, Suite A1-100 West Lafayette IN 47906 | Vice President Of Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-01 | 26,178 | $3.06 | 150,579 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-01 | 18,194 | $5.03 | 132,385 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-01 | 5,037 | $5.05 | 127,348 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-12-01 | 26,178 | $0.00 | 26,178 | $3.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-02-12 | No | 4 | M | Direct |
Footnotes
- Represents the sale of 18,194 shares in multiple transactions, ranging in price from $5.0000 to $5.1100, resulting in a weighted-average sale price per share of $5.0318. The reporting person will provide, upon request by SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
- Represents the sale of 5,037 shares in multiple transactions, ranging in price from $5.0000 to $5.1100, resulting in a weighted-average sale price per share of $5.0495. The reporting person will provide, upon request by SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
- The option is fully vested and immediately exercisable.
Billionaire Hedge Funds
